Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 5:8:811223.
doi: 10.3389/fsurg.2021.811223. eCollection 2021.

Editorial: Transplant Oncology of Liver Malignancies

Cheng-Maw Ho  1
Affiliations
Editorial

Editorial: Transplant Oncology of Liver Malignancies

Cheng-Maw Ho. Front Surg. .
No abstract available

Keywords: hepatocellular carcinoma; liver transplantation; malignancy; risk factors; transplant oncology.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Transplant Oncology of Liver Malignancies

Similar articles

See all similar articles

References

    1. Sapisochin G, Hibi T, Ghobrial M, Man K. The ILTS Consensus Conference on transplant oncology: Setting the stage. Transplantation. (2020) 104:1119–20. 10.1097/TP.0000000000003175 - DOI - PubMed
    1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. . Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. (1996) 334:693–9. 10.1056/NEJM199603143341104 - DOI - PubMed
    1. Ho CM, Hu RH, Wu YM, Ho MC, Lee PH. Cross-match as an immuno-oncological risk factor for hepatocellular carcinoma recurrence and inferior survival after living donor liver transplantation: a call for further investigation. Clin Med Insights Oncol. (2020) 14:1179554920968774. 10.1177/1179554920968774 - DOI - PMC - PubMed
    1. Ho CM, Wu CY, Lee PH, Lai HS, Ho MC, Wu YM, et al. . Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma. Ann Surg Oncol. (2013) 20:2526–33. 10.1245/s10434-013-2940-7 - DOI - PubMed
    1. Ho CM, Lee CH, Lee MC, Zhang JF, Chen CH, Wang JY, et al. . Survival after treatable hepatocellular carcinoma recurrence in liver recipients: a nationwide cohort analysis. Front Oncol. (2021) 10:616094. 10.3389/fonc.2020.616094 - DOI - PMC - PubMed

Publication types

LinkOut - more resources